Biogen Canada was established in Mississauga, Ontario in April 1998 and has been proudly serving Canadians for more than 25 years. Biogen Canada is a trusted leader in the fields of multiple sclerosis (MS) and spinal muscular atrophy (SMA) and is deepening its commitment to new therapy areas like Friedreich ataxia (FA), amyotrophic lateral sclerosis (ALS), neuropsychiatry and Alzheimer’s disease (AD), while supporting greater access and the sustainability of health systems through biosimilars.